Biocon Biologics Integrates Viatris Business As It Introduces Adalimumab

Completes ‘First Wave’ Of Viatris Integration And Launches US Hulio Rival To Humira

 
• By Dave Wallace
  
Biocon logo with silhouette of vials and syringe
Multiple developments have been seen for Biocon’s biosimilars business • Source: Shutterstock

More from Biosimilars

More from Products